Literature DB >> 9139133

[Case of allergic bronchopulmonary mycosis caused by Schizophyllum commune].

S Yamashina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9139133

Source DB:  PubMed          Journal:  Jpn J Antibiot        ISSN： 0368-2781


× No keyword cloud information.
  5 in total

1.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

2.  A favorable clinical effect of an expectorant in allergic bronchopulmonary mycosis caused by Schizophyllum commune.

Authors:  Haruki Kobayashi; Tetsuhiko Taira; Kazushige Wakuda; Toshiaki Takahashi; Masahiro Endo
Journal:  Respir Med Case Rep       Date:  2016-07-17

3.  First report on cutaneous infectious granuloma caused by Schizophyllum commune.

Authors:  Lidi Tian; Yunzhu Mu; Hao Zhang; Xiaocui Su; Chuan Yang; Xianzhu Shu; Defu Qing
Journal:  BMC Infect Dis       Date:  2018-06-26       Impact factor: 3.090

4.  Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi.

Authors:  Takashi Ishiguro; Noboru Takayanagi; Daidou Tokunaga; Kazuyoshi Kurashima; Aya Matsushita; Keiji Harasawa; Koichiro Yoneda; Noriko Tsuchiya; Shozaburo Yamaguchi; Yousuke Miyahara; Ryozo Yano; Hiroo Saito; Mikio Ubukata; Tsutomu Yanagisawa; Yutaka Sugita; Yoshinori Kawabata
Journal:  Yale J Biol Med       Date:  2007-09

5.  Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.

Authors:  Takashi Ishiguro; Naho Kagiyama; Ayako Kojima; Masami Yamada; Yasuo Nakamoto; Yotaro Takaku; Yoshihiko Shimizu; Kazuyoshi Kurashima; Noboru Takayanagi
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.